Cargando…
Modulation of G-protein activation, calcium currents and opioid receptor phosphorylation by the pH-dependent antinociceptive agonist NFEPP
N-(3-fluoro-1-phenethylpiperidine-4-yl)-N-phenyl propionamide is a newly-designed pain killer selectively activating G-protein-coupled mu-opioid receptors (MOR) in acidic injured tissues, and therefore devoid of central side effects which are typically elicited at normal pH values in healthy tissues...
Autores principales: | Celik, Melih Özgür, Seitz, Viola, Yergöz, Fatih, Dembla, Sandeep, Blum, Nina Kathleen, Schulz, Stefan, Stein, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213447/ https://www.ncbi.nlm.nih.gov/pubmed/37251645 http://dx.doi.org/10.3389/fnmol.2023.1171855 |
Ejemplares similares
-
Amelioration of injury-induced tissue acidosis by a nonsteroidal analgesic attenuates antinociceptive effects of the pH-dependent opioid agonist NFEPP
por: Celik, Melih Ö., et al.
Publicado: (2022) -
The Hypnotic, Anxiolytic, and Antinociceptive Profile of a Novel µ-Opioid Agonist
por: Montes, Guilherme Carneiro, et al.
Publicado: (2017) -
Mu-Opioid Receptor Agonist Induces Kir3 Currents in Mouse Peripheral Sensory Neurons – Effects of Nerve Injury
por: Stötzner, Philip, et al.
Publicado: (2018) -
Distinct roles of exogenous opioid agonists and endogenous opioid peptides in the peripheral control of neuropathy-triggered heat pain
por: Labuz, Dominika, et al.
Publicado: (2016) -
PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability
por: France, Charles P, et al.
Publicado: (2016)